Laboratory of Immune Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda.
Clinical Fellowship Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda.
J Allergy Clin Immunol. 2023 Jan;151(1):81-97. doi: 10.1016/j.jaci.2022.10.011. Epub 2022 Oct 19.
T cells are critical orchestrators of the adaptive immune response that optimally eliminate a specific pathogen. Aberrant T-cell development and function are implicated in a broad range of human disease including immunodeficiencies, autoimmune diseases, and allergic diseases. Accordingly, therapies targeting T cells and their effector cytokines have markedly improved the care of patients with immune dysregulatory diseases. Newer discoveries concerning T-cell-mediated antitumor immunity and T-cell exhaustion have further prompted development of highly effective and novel treatment modalities for malignancies, including checkpoint inhibitors and antigen-reactive T cells. Recent discoveries are also uncovering the depth and variability of T-cell phenotypes: while T cells have long been described using a subset-based classification system, next-generation sequencing technologies suggest an astounding degree of complexity and heterogeneity at the single-cell level.
T 细胞是适应性免疫反应的关键调控者,能够最佳地清除特定病原体。T 细胞发育和功能异常与广泛的人类疾病有关,包括免疫缺陷、自身免疫性疾病和过敏性疾病。因此,针对 T 细胞及其效应细胞因子的治疗方法显著改善了免疫失调疾病患者的治疗效果。关于 T 细胞介导的抗肿瘤免疫和 T 细胞耗竭的新发现进一步促使开发了针对恶性肿瘤的高效和新型治疗方法,包括检查点抑制剂和抗原反应性 T 细胞。最近的发现还揭示了 T 细胞表型的深度和可变性:虽然 T 细胞长期以来一直使用基于亚群的分类系统进行描述,但下一代测序技术表明,在单细胞水平上存在惊人的复杂性和异质性。